Literature DB >> 20944007

Temporal differences in the dependency on phosphoinositide-dependent kinase 1 distinguish the development of invariant Valpha14 NKT cells and conventional T cells.

David K Finlay1, April P Kelly, Rosemary Clarke, Linda V Sinclair, Maria Deak, Dario R Alessi, Doreen A Cantrell.   

Abstract

This study uses two independent genetic strategies to explore the requirement for phosphoinositide-dependent kinase-1 (PDK1) in the development of mature T cell populations from CD4/CD8 double-positive thymocytes. The data show that CD4/CD8 double-positive thymocytes that do not express PDK1 or express a catalytically inactive PDK1 mutant fail to produce mature invariant Vα14 NKT cells but can differentiate to conventional CD4, CD8, or regulatory T cell subsets in the thymus. The PDK1 requirement for Vα14 NKT cell development reflects that these cells require the PDK1 substrate protein kinase B to meet the metabolic demands for proliferative expansion in response to IL-15 or AgR stimulation. There is also constitutive PDK1 signaling in conventional α/β T cells that is not required for lineage commitment of these cells but fine-tunes the expression of coreceptors and adhesion molecules. Also, although PDK1 is dispensable for thymic development of conventional α/β T cells, peripheral cells are reduced substantially. This reflects a PDK1 requirement for lymphopenia-induced proliferation, a process necessary for initial population of the peripheral T cell niche in neonatal mice. PDK1 is thus indispensable for T cell developmental programs, but the timing of the PDK1 requirement is unique to different T cell subpopulations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20944007      PMCID: PMC3014570          DOI: 10.4049/jimmunol.1000827

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  CD69 expression discriminates MHC-dependent and -independent stages of thymocyte positive selection.

Authors:  K J Hare; E J Jenkinson; G Anderson
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

2.  Regulation of NKT cell development by SAP, the protein defective in XLP.

Authors:  Kim E Nichols; Jamie Hom; Shun-You Gong; Arupa Ganguly; Cindy S Ma; Jennifer L Cannons; Stuart G Tangye; Pamela L Schwartzberg; Gary A Koretzky; Paul L Stein
Journal:  Nat Med       Date:  2005-02-13       Impact factor: 53.440

3.  CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.

Authors:  T Kawano; J Cui; Y Koezuka; I Toura; Y Kaneko; K Motoki; H Ueno; R Nakagawa; H Sato; E Kondo; H Koseki; M Taniguchi
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

4.  Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation.

Authors:  Marisa M Juntilla; Jessica A Wofford; Morris J Birnbaum; Jeffrey C Rathmell; Gary A Koretzky
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-03       Impact factor: 11.205

5.  'Coreceptor tuning': cytokine signals transcriptionally tailor CD8 coreceptor expression to the self-specificity of the TCR.

Authors:  Jung-Hyun Park; Stanley Adoro; Philip J Lucas; Sophia D Sarafova; Amala S Alag; Loretta L Doan; Batu Erman; Xiaolong Liu; Wilfried Ellmeier; Remy Bosselut; Lionel Feigenbaum; Alfred Singer
Journal:  Nat Immunol       Date:  2007-09-16       Impact factor: 25.606

6.  Characterization of the early stages of thymic NKT cell development.

Authors:  Kamel Benlagha; Datsen G Wei; Joel Veiga; Luc Teyton; Albert Bendelac
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307

7.  The Src family tyrosine kinase Fyn regulates natural killer T cell development.

Authors:  P Gadue; N Morton; P L Stein
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

8.  The kinase PDK1 integrates T cell antigen receptor and CD28 coreceptor signaling to induce NF-kappaB and activate T cells.

Authors:  Sung-Gyoo Park; Jan Schulze-Luehrman; Matthew S Hayden; Naoko Hashimoto; Wataru Ogawa; Masato Kasuga; Sankar Ghosh
Journal:  Nat Immunol       Date:  2009-01-04       Impact factor: 25.606

9.  The p110delta catalytic isoform of PI3K is a key player in NK-cell development and cytokine secretion.

Authors:  Nayoung Kim; Aurore Saudemont; Louise Webb; Montserrat Camps; Thomas Ruckle; Emilio Hirsch; Martin Turner; Francesco Colucci
Journal:  Blood       Date:  2007-07-20       Impact factor: 22.113

10.  Notch-induced T cell development requires phosphoinositide-dependent kinase 1.

Authors:  April P Kelly; David K Finlay; Heather J Hinton; Rosie G Clarke; Emma Fiorini; Freddy Radtke; Doreen A Cantrell
Journal:  EMBO J       Date:  2007-06-28       Impact factor: 11.598

View more
  17 in total

1.  A unique role for ITK in survival of invariant NKT cells associated with the p53-dependent pathway in mice.

Authors:  Qian Qi; Weishan Huang; Yuting Bai; Gabriel Balmus; Robert S Weiss; Avery August
Journal:  J Immunol       Date:  2012-03-07       Impact factor: 5.422

Review 2.  The ins and outs of type I iNKT cell development.

Authors:  Susannah C Shissler; Tonya J Webb
Journal:  Mol Immunol       Date:  2018-11-28       Impact factor: 4.407

Review 3.  NF-κB control of T cell development.

Authors:  Steve Gerondakis; Thomas S Fulford; Nicole L Messina; Raelene J Grumont
Journal:  Nat Immunol       Date:  2014-01       Impact factor: 25.606

4.  Cutting edge: Discrete functions of mTOR signaling in invariant NKT cell development and NKT17 fate decision.

Authors:  Jun Wei; Kai Yang; Hongbo Chi
Journal:  J Immunol       Date:  2014-09-26       Impact factor: 5.422

5.  Critical role for miR-181a/b-1 in agonist selection of invariant natural killer T cells.

Authors:  Natalia Ziętara; Marcin Łyszkiewicz; Katrin Witzlau; Ronald Naumann; Robert Hurwitz; Jörg Langemeier; Jens Bohne; Inga Sandrock; Matthias Ballmaier; Siegfried Weiss; Immo Prinz; Andreas Krueger
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

6.  mTORC2 regulates multiple aspects of NKT-cell development and function.

Authors:  Tammarah Sklarz; Peng Guan; Mercy Gohil; Renee M Cotton; Moyar Q Ge; Angela Haczku; Rupali Das; Martha S Jordan
Journal:  Eur J Immunol       Date:  2017-01-27       Impact factor: 5.532

7.  Mammalian target of rapamycin complex 2 regulates invariant NKT cell development and function independent of promyelocytic leukemia zinc-finger.

Authors:  Nicolas Prevot; Kalyani Pyaram; Evan Bischoff; Jyoti Misra Sen; Jonathan D Powell; Cheong-Hee Chang
Journal:  J Immunol       Date:  2014-11-17       Impact factor: 5.422

8.  The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis.

Authors:  Jorge Henao-Mejia; Adam Williams; Loyal A Goff; Matthew Staron; Paula Licona-Limón; Susan M Kaech; Maki Nakayama; John L Rinn; Richard A Flavell
Journal:  Immunity       Date:  2013-04-25       Impact factor: 31.745

Review 9.  mTOR and its tight regulation for iNKT cell development and effector function.

Authors:  Wei Yang; Balachandra Gorentla; Xiao-Ping Zhong; Jinwook Shin
Journal:  Mol Immunol       Date:  2015-08-04       Impact factor: 4.407

10.  NKAP Regulates Invariant NKT Cell Proliferation and Differentiation into ROR-γt-Expressing NKT17 Cells.

Authors:  Puspa Thapa; Meibo W Chen; Douglas C McWilliams; Paul Belmonte; Megan Constans; Derek B Sant'Angelo; Virginia Smith Shapiro
Journal:  J Immunol       Date:  2016-05-09       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.